title: Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
authors.forename: Lothar Bernd
authors.initials: LB
authors.lastname: Zimmerhackl
authors.forename: Johannes
authors.initials: J
authors.lastname: Hofer
authors.forename: Gérard
authors.initials: G
authors.lastname: Cortina
authors.forename: Walter
authors.initials: W
authors.lastname: Mark
authors.forename: Reinhard
authors.initials: R
authors.lastname: Würzner
authors.forename: Therese C
authors.initials: TC
authors.lastname: Jungraithmayr
authors.forename: Gus
authors.initials: G
authors.lastname: Khursigara
authors.forename: Kay O
authors.initials: KO
authors.lastname: Kliche
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Radauer
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D003167:Complement Activation / Q000187:drug effects; D003176:Complement C3 / Q000378:metabolism; D017242:Complement Factor H / Q000235:genetics; D051056:Complement Inactivating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects*; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D009154:Mutation; D055502:Secondary Prevention
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003176:Complement C3; D051056:Complement Inactivating Agents; D017242:Complement Factor H; C481642:eculizumab